“Managment of Relapsed Refractory ALL With Inotuzumab During COVID-19. A Casr Report”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 14, no. 1, Apr. 2022, p. e2022043, https://doi.org/10.4084/MJHID.2022.043.